2015 Strategies in the European Nucleic Acid Testing Market

 Published On: May, 2015 |    No of Pages: 1273 |  Published By: VPG Market Research | Format: PDF
Request Free Sample

This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years.

I. Introduction
II. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies For Decentralized Testing Markets
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge And Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Worldwide Market and Technology Review
A. DNA Sequencing
1. Introduction
2. Sequencing Methods
3. Autoradiography
4. The Human Genome Project
5. Sequencing Automation
6. Image Scanners
7. Fluorescent Detection
8. Gene Profiling
9. Gene Expression
10. Polymorphism Screening
11. Protein Interaction Networks
B. DNA and RNA Probe Technologies
1. Basic Principles
2. Probe Preparation
3. The DNA Probe Test
4. Test Formats
5. Labeling Techniques
6. Amplification Methods
C. Detection Technologies
1. Radioactive Methods
a. Overview
b. Major Isotopes
O P-32
O S-35
O H-3
O I-125
2. Non-Isotopic Methods
a. Enzymatic Labels
b. Chemical Labeling
O Indirect Chemical Labeling
O Direct Chemical Labeling
c. Fluorescence
d. Chemiluminescence
e. Electrical Conductivity
D. Molecular Diagnostic Instrumentation Review
1. Abbott LCx
2. Beckman Coulter/Biomek FK
3. BD Viper System with XTR Technology
4. BD Innova
5. Becton Dickinson SDA
6. bioMerieux NucliSENS easyMAG
7. bioMerieux NucliSENS easyQ and MiniMAG
8. Bio-Rad GeneScope
9. Cepheid GeneXpert
10. Curetis Unyvero
11. GenMark Dx eSensor XT-8
12. Hologic/Gen-Probe Panther
13. Hologic/Gen-Probe Tigris/DTS
14. HTG Molecular Edge
15. Life Technologies QuantStudio Dx
16. Qiagen QIAsymphony RGQ
17. Roche Cobas Amplicor
18. Roche Cobas TaqMan 48
19. Roche Cobas TaqMan
20. Roche Cobas TaqMan AmpliPrep
21. Roche LighCycler 480
22. Roche Cobas 4800
23. Roche Cobas s 201
24. Siemens Versant
25. Tecan LS Series
E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
- Liquid Transportation and Mixing
- Separation
- Reaction
- Detection
F. Pharmacogenomics
G. Major Applications
1. Microbiology/Infectious Diseases
a. Overview
b. Major Infectious Diseases
AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
Adenovirus
Aeromonas
Anthrax/Bacillus Anthracis
Arboviruses
Babesiosis
Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
Blastocystis Hominis
Brucella
Campylobacter
Candida
Chagas Disease
Chancroid
Chlamydia
Clostridium Difficile
Coronaviruses
Coxsackieviruses
Creutzfeldt-Jakobís Disease
Cryptosporidium Parvum
Cyclospora Cayetanensis
Cytomegalovirus
Ebola Virus
E. Coli
EchoVirus
Encephalitis
Enteroviruses
Epstein-Barr Virus
Giardia Lamblia
Gonorrhea
Granuloma Inguinale
Hantavirus
Helicobacter Pylori
Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, ALT/SGPT
Herpes Simplex Virus
Human Herpes Virus-6 (HHV-6)
Influenza Viruses
Legionella
Lyme Disease
Lymphogranuloma Venereum (LGV)
Malaria
Measles (Rubeola)
Meningitis
Microsporidium
Mononucleosis
Mumps
Mycoplasma
Papillomaviruses
Parvovirus B19
Pneumonia
Polyomaviruses
Pseudomonas Aeruginosa
Rabies
Respiratory Syncytial Virus (RSV)
Rhinoviruses
Rotavirus
Rubella
Salmonellosis
Septicemia
Shigellosis
Staphylococcus Aureus
Streptococci
Syphilis
Toxoplasmosis
Trichomonas Vaginalis
Tuberculosis
Vibrio
West Nile Virus
Yersina
2. Cancer Testing
a. Overview
b. Major Cancer Types
* Prostate
* Lung
* Colon and Rectum
* Breast
* Skin
* Uterine
* Leukemia
* Oral
c. Oncogenes
Abl/abl-bcr
AIB1
BCL-2
BRCA1
CD44
C-fos
C-myb
C-myc
CYP17
Erb-B
HPC1
N-myc
P40
P51
P53
PIK3CA
PTI-1
Ras
Reg
Sis
Src
3. Genetic Diseases
a. Overview
b. Nucleic Acid Amplification
c. Chromosome Imaging
d. Genomics Technologies
e. Proteomics Technologies
f. Current Pharmacogenomic Tests
g. Future Pharmacogenomic Testing
h. Major Diseases
* Achondroplasia
* Autosomal Dominant Polycystic Kidney Disease
* Cancer
* Cosmetogenomics
* Cystic Fibrosis
* Down's Syndrome
* Duchenne and Becker Muscular Dystrophy
* Factor V (Leiden)
* Factor IX Deficiency
* Fragile X Syndrome
* Heart Disease
* Hemochomatosis
* Hemophilia
* Huntington's Disease
* Maternal-Fetal Incompatibility
* Multiple Endocrine Neoplasia
* Phenylketonuria (PKU)
* Polycystic Kidney Disease (PKD)
* Prenatal Screening
* Retinitis Pigmentosa
* Retinoblastoma
* Sickle Cell Anemia
* Spinal Muscular Atrophy
* Vitamin B12 Metabolism
i. Social Issues and Concerns
4. Forensic Testing
a. Overview
b. Multilocus and Single Locus Probes
* Multilocus Probes
* Single Locus Probes
* PCR and RFLP
c. The FBI
d. DNA Profile Data Banks
* U.S.A.
* U.K.
e. Judicial Implementation
f. Major Crime Categories
g. Factors Contributing to the DNA Probe Market Expansion
* Technology Availability
* Use of Hair as Evidence
h. Wildlife Forensics
5. Paternity Testing/HLA Typing
6. Other Applications
a. Disease Susceptibility Testing
b. Cardiovascular Diseases
c. Diabetes
d. Alzheimer's Disease
e. Periodontal Disease
f. Plasma Purification
g. Organ Transplantation
h. Water Contamination
i. Other
H. Competing/complementing
1. Monoclonal Antibodies/Immunoassays
2. RNA Probes
3. Two-Dimensional Electrophoresis
4. Flow Cytometry
VII. France Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
VIII. Germany Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts,
Major Supplier Sales and Market Shares
IX. Italy Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
X. Spain Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
XI. U.K. Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
XII. Competitive Assessments
- Abbott
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Biotest
- Cepheid
- CellMark Forenciscs/LabCorp
- Decode Genetics
- Diadexus
- Eiken
- Elitech Group
- Enzo
- Exact Sciences
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- Illumina
- Kreatech
- Li-Cor Biosciences
- Monogram Biosciences/LabCorp
- Myriad Genetics
- Ortho-Clinical Diagnostics
- Perkin Elmer/Caliper
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- Shimadzu
- Siemens
- Sierra Molecular
- Takara Bio
- Tecan Group
- Thermo Fisher
XIII. Appendix: Major Universities and Research Centers Developing Molecular Diagnostic Technologies

List of Tables
Major Companies Developing or Marketing AIDS Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Bartonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Candida Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Clostridium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Coronavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hantavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Helicobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Influenza Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Measles Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Meningitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mumps Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing RSV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rotavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rubella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Septicemia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Syphilis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Trichomonas Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic and Other Direct Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases
France Molecular Diagnostics Test Volume And Sales By Major Application 2014-2019
France Laboratories Performing DNA Sequencing By Market Segment 2014
France Molecular Diagnostics Market Potential Laboratory Universe by Market Segment 2014
France Molecular Diagnostics Test Volume By Major Application 2014-2019
France Major Infectious Disease Test Volume by Assay 2014-2019
France Major Infectious Disease Test Volume by Method 2014
France Molecular Diagnostics Market By Major Application 2014-2019
France Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers 2014
France Major Infectious Disease Diagnostics Market by Assay 2014-2019
France AIDS Testing Market Estimated Sales by Major Supplier 2014
France Adenovirus Testing Market Estimated Sales by Major Supplier 2014
France Chlamydia Testing Market Estimated Sales by Major Supplier 2014
France CMV Testing Market Estimated Sales by Major Supplier 2014
France Gonorrhea Testing Market Estimated Sales by Major Supplier 2014
France Hepatitis Testing Market Estimated Sales by Major Supplier 2014
France Hepatitis C Testing Market Estimated Sales by Major Supplier 2014
France HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier 2014
France Herpes Testing Market Estimated Sales by Major Supplier 2014
France Influenza Testing Market Estimated Sales by Major Supplier 2014
France Meningitis Testing Market Estimated Sales by Major Supplier 2014
France Mycoplasma Testing Market Estimated Sales by Major Supplier 2014
France RSV Testing Market Estimated Sales by Major Supplier 2014
France Shigella Testing Market Estimated Sales by Major Supplier 2014
Germany Molecular Diagnostics Test Volume And Sales By Major Application 2014-2019
Germany Laboratories Performing DNA Sequencing By Market Segment 2014
Germany Molecular Diagnostics Market Potential Laboratory Universe by Market Segment 2014
Germany Molecular Diagnostics Test Volume By Major Application 2014-2019
Germany Major Infectious Disease Test Volume by Assay 2014-2019
Germany Major Infectious Disease Test Volume by Method 2014
Germany Molecular Diagnostics Market By Major Application 2014-2019
Germany Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers 2014
Germany Major Infectious Disease Diagnostics Market by Assay 2014-2019
Germany AIDS Testing Market Estimated Sales by Major Supplier 2014
Germany CMV Testing Market Estimated Sales by Major Supplier 2014
Germany EBV Testing Market Estimated Sales by Major Supplier 2014
Germany Gonorrhea Testing Market Estimated Sales by Major Supplier 2014
Germany Hepatitis Testing Market Estimated Sales by Major Supplier 2014
Germany Hepatitis C Testing Market Estimated Sales by Major Supplier 2014
Germany HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier 2014
Germany Herpes Testing Market Estimated Sales by Major Supplier 2014
Germany Influenza Testing Market Estimated Sales by Major Supplier 2014
Germany Meningitis Testing Market Estimated Sales by Major Supplier 2014
Germany Mycoplasma Testing Market Estimated Sales by Major Supplier 2014
Germany Pneumonia Testing Market Estimated Sales by Major Supplier 2014
Germany RSV Testing Market Estimated Sales by Major Supplier 2014
Germany Rotavirus Testing Market Estimated Sales by Major Supplier 2014
Italy Molecular Diagnostics Test Volume And Sales By Major Application 2014-2019
Italy Laboratories Performing DNA Sequencing By Market Segment 2014
Italy Molecular Diagnostics Market Potential Laboratory Universe by Market Segment 2014
Italy Molecular Diagnostics Test Volume By Major Application 2014-2019
Italy Major Infectious Disease Test Volume by Assay 2014-2019
Italy Major Infectious Disease Test Volume by Method 2014
Italy Molecular Diagnostics Market By Major Application 2014-2019
Italy Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers 2014
Italy Major Infectious Disease Diagnostics Market by Assay 2014-2019
Italy AIDS Testing Market Estimated Sales by Major Supplier 2014
Italy CMV Testing Market Estimated Sales by Major Supplier 2014
Italy Gonorrhea Testing Market Estimated Sales by Major Supplier 2014
Italy Hepatitis Testing Market Estimated Sales by Major Supplier 2014
Italy Hepatitis C Testing Market Estimated Sales by Major Supplier 2014
Italy HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier 2014
Italy Herpes Testing Market Estimated Sales by Major Supplier 2014
Italy Influenza Testing Market Estimated Sales by Major Supplier 2014
Italy Meningitis Testing Market Estimated Sales by Major Supplier 2014
Italy Mycoplasma Testing Market Estimated Sales by Major Supplier 2014
Italy RSV Testing Market Estimated Sales by Major Supplier 2014
Spain Molecular Diagnostics Test Volume And Sales By Major Application 2014-2019
Spain Laboratories Performing DNA Sequencing By Market Segment 2014
Spain Molecular Diagnostics Market Potential Laboratory Universe by Market Segment 2014
Spain Molecular Diagnostics Test Volume By Major Application 2014-2019
Spain Major Infectious Disease Test Volume by Assay 2014-2019
Spain Major Infectious Disease Test Volume by Method 2014
Spain Molecular Diagnostics Market By Major Application 2014-2019
Spain Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers 2014
Spain Major Infectious Disease Diagnostics Market by Assay 2014-2019
Spain AIDS Testing Market Estimated Sales by Major Supplier 2014
Spain Chlamydia Testing Market Estimated Sales by Major Supplier 2014
Spain CMV Testing Market Estimated Sales by Major Supplier 2014
Spain Gonorrhea Testing Market Estimated Sales by Major Supplier 2014
Spain Hepatitis Testing Market Estimated Sales by Major Supplier 2014
Spain Hepatitis C Testing Market Estimated Sales by Major Supplier 2014
Spain HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier 2014
Spain Herpes Testing Market Estimated Sales by Major Supplier 2014
Spain Influenza Testing Market Estimated Sales by Major Supplier 2014
Spain Meningitis Testing Market Estimated Sales by Major Supplier 2014
Spain Mycoplasma Testing Market Estimated Sales by Major Supplier 2014
U.K. Molecular Diagnostics Test Volume And Sales By Major Application 2014-2019
U.K. Laboratories Performing DNA Sequencing By Market Segment 2014
U.K. Molecular Diagnostics Market Potential Laboratory Universe by Market Segment 2014
U.K. Molecular Diagnostics Test Volume By Major Application 2014-2019
U.K. Major Infectious Disease Test Volume by Assay 2014-2019
U.K. Major Infectious Disease Test Volume by Method 2014
U.K. Molecular Diagnostics Market By Major Application 2014-2019
U.K. Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers 2014
U.K. Major Infectious Disease Diagnostics Market by Assay 2014-2019
U.K. AIDS Testing Market Estimated Sales by Major Supplier 2014
U.K. Gonorrhea Testing Market Estimated Sales by Major Supplier 2014
U.K. Hepatitis Testing Market Estimated Sales by Major Supplier 2014
U.K. Hepatitis C Testing Market Estimated Sales by Major Supplier 2014
U.K. HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier 2014
U.K. Influenza Testing Market Estimated Sales by Major Supplier 2014
U.K. Mycoplasma Testing Market Estimated Sales by Major Supplier 2014
U.K. Pneumonia Testing Market Estimated Sales by Major Supplier 2014
U.K. Shigella Testing Market Estimated Sales by Major Supplier 2014


If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.